US Broker Ratings

AbbVie Inc. (ABBV) Investor Outlook: Analyzing a Robust 7.87% Potential Upside

AbbVie Inc. (NYSE: ABBV) stands as a formidable player in the healthcare sector, particularly within the drug manufacturers’ industry. With a market capitalization of $400.88 billion,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A Strong Consensus with 7.64% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) has been catching the eyes of investors with its solid standing in the healthcare sector, particularly in the Health Information..

UnitedHealth Group (UNH) Stock Analysis: Navigating a 19.80% Potential Upside in the Healthcare Sector

In the dynamic landscape of healthcare investments, UnitedHealth Group Incorporated (NYSE: UNH) stands out as a formidable player with a market cap of $296.59 billion. As..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Unveiling a 7.2% Potential Upside and Robust Pipeline

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is carving out a prominent niche within the healthcare sector, specifically in the biotechnology industry. Headquartered in Boston, Massachusetts, Vertex has..

CVS Health Corporation (CVS): Investor Outlook with a 21% Potential Upside

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, stands as a formidable presence with a market capitalization of $98.66 billion. As a key..

Eli Lilly (LLY) Stock Analysis: Strong Revenue Growth and Analyst Confidence Propel Investor Interest

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its robust performance and strategic growth initiatives. The..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Solid Buy Ratings and 12% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a leading player in the healthcare sector, continues to capture investor interest with its robust market presence and promising growth..

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 31.64% Potential Upside in the Medical Device Sector

Boston Scientific Corporation (NYSE: BSX), a leader in the medical device industry, is making waves among investors with a projected upside of 31.64%. With a market..

Amgen Inc. (AMGN) Investor Outlook: Strong Revenue Growth and Robust Dividend Yield in Focus

Amgen Inc. (NASDAQ: AMGN), a leading player in the healthcare sector, continues to capture investor attention with its robust performance metrics and strategic positioning within the..

Medtronic plc (MDT) Stock Analysis: A Robust Medical Device Giant with 12.51% Potential Upside

Investors seeking a reliable player in the healthcare sector could find Medtronic plc (NYSE: MDT) a compelling addition to their portfolios. As a leader in the..

Stryker Corporation (SYK) Stock Analysis: Evaluating a 20.53% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a heavyweight in the healthcare sector with a robust $135.84 billion market capitalization, stands as a pivotal player in the medical devices..

Abbott Laboratories (ABT) Investor Outlook: Analyzing a 15% Potential Upside in the Healthcare Giant

Abbott Laboratories (NYSE: ABT) remains a stalwart in the healthcare sector, boasting a rich history dating back to its founding in 1888. With a current market..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Powerhouse with a Robust Upside Potential

For investors seeking exposure to the healthcare sector, Novo Nordisk A/S (NVO) presents a compelling opportunity. As a leader in the drug manufacturing industry, specifically focused..

Standard BioTools Inc. (LAB) Investor Outlook: Navigating the Volatility in Medical Device Sector

Standard BioTools Inc. (NASDAQ: LAB) is a noteworthy entity within the healthcare sector, specifically in the medical devices industry. With a market capitalization of approximately $638.38..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring 116.77% Potential Upside in Biotechnology

Prothena Corporation plc (NASDAQ: PRTA), an advanced-stage biotechnology company headquartered in Dublin, Ireland, emerges as a compelling prospect within the healthcare sector. Focused on the discovery..

Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Visionary with a 607.85% Potential Upside

Investors with an eye on the biotechnology sector might want to keep Humacyte, Inc. (HUMA) on their radar. This Durham, North Carolina-based company is pioneering the..

Oric Pharmaceuticals (ORIC) Stock Analysis: Exploring a 157% Upside Potential in the Biotech Arena

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company based out of South San Francisco, is gaining attention in the biotechnology sector for its innovative approach..

Inventiva S.A. (IVA): Biotech Stock with a 265% Potential Upside – An Investor’s Outlook

Inventiva S.A. (IVA), a clinical-stage biopharmaceutical company based in Daix, France, is catching the attention of investors with its ambitious pipeline and strong analyst ratings. Specializing..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a 76% Potential Upside in CNS Therapeutics

Rapport Therapeutics, Inc. (RAPP), a burgeoning player in the biotechnology sector, is catching the eye of investors with its promise of significant upside potential. Based in..

Personalis, Inc. (PSNL) Investor Outlook: Unpacking the 38.80% Potential Upside in Cancer Genomics

For investors with a keen interest in the healthcare sector, particularly within the diagnostics and research arena, Personalis, Inc. (NASDAQ: PSNL) presents a compelling opportunity. Situated..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds